# Perioperative Apalutamide in High-Risk Localized Prostate Cancer

Source: [nejm.org](https://www.nejm.org/doi/full/10.1056/NEJMc2611613?af=R&rss=currentIssue) · 2026-11-11 · Medicine
Page: https://themorning.science/story/perioperative-apalutamide-in-high-risk-localized-prostate-cancer-cbacdfb8e8af6627
Kind: research · Impact: medium

## In brief

- The New England Journal of Medicine published a letter titled "Perioperative Apalutamide in High-Risk Localized Prostate Cancer".
- The item appears in volume 395, issue 19, pages 1965-1968, with an issue date of November 12, 2026.
- The available source is only the listing page and gives no further trial data or results.

## Why it matters

Clinicians and readers following prostate cancer treatment can use this NEJM item to locate the report on perioperative apalutamide in high-risk localized disease; the source itself does not describe its findings.

## Timeline

- 2026-11-11: Published online on nejm.org
- 2026-11-12: Appears in NEJM volume 395, issue 19, pages 1965-1968

## Coverage

- [Perioperative Apalutamide in High-Risk Localized Prostate Cancer](https://www.nejm.org/doi/full/10.1056/NEJMc2611613?af=R&rss=currentIssue) — nejm.org, 2026-11-11

Tags: prostate cancer, apalutamide, oncology, urology, perioperative therapy

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science